The Disclosure Code has been established to define and provide a framework for the cooperation between pharmaceutical industry and healthcare professionals; it is a step towards enhanced transparency and trust between the pharmaceutical industry, the medical community, and the civil society throughout Europe.
The Disclosure Code includes the disclosure of the benefits provided by the pharmaceutical industry to HCPs and SHBs and provides for the detailed disclosure of the amount and nature of these grants.
The EFPIA Code |
The SFEE Disclosure Code |
AnaBIOsis fully supports the strengthening of transparency in the relations between the pharmaceutical industry and healthcare professionals as well as scientific healthcare bodies, thereby ensuring compliance with the EFPIA Disclosure Code, the SFEE Code of Conduct and the local legislation (Article 66 (7) 4136 / 2014 Government Gazette A270 / 24.12.2014).
Related Government Gazette A270 / 24.12.2014
The information disclosed includes transfers of value to healthcare professionals and scientific healthcare bodies regarding the following categories:
| Categories |
Transfer of value |
| Healthcare Professionals |
Scientific Healthcare Bodies |
| Donations and Sponsorships |
|
Payment in kind or in cash |
| Events |
Registration cost, Travel and Accommodation Expenses |
|
| Advisory and other services |
Fees for scientific-medical advisory, educational and other services |
| Research & Development |
Remunerations, Travel & accommodation expenses and any other related expenses covered and associated with this service |
Reporting period: Each report covers the transfers of value occurring in one calendar year and disclosed in the next year. For example, the first report to be published in June 2016 covers the transfers of value in 2015.
| PUBLICATION OF DATA: |
2018
2017
2016
2015 |